BD a leading global medical technology company, announced the launch of the HemoSphere Stream™ Module, a new innovation which gives clinicians continuous, noninvasive visibility into patients' blood...

Curve Biosciences, the Whole-Body Intelligence™ company, announced the appointment of Amit Singal, M.D., as Chief Medical Officer. 

K-Pharmacy is rapidly emerging as one of the most trusted and fast-growing retail channels in Korea's beauty industry, attracting increasing attention from global...

Epia Neuro, a brain computer interface company developing intent-driven systems to restore independence for people living with neurological conditions, announced its official...

A team led by principal investigators Bobo Dang and Ting Zhou at Westlake University/Westlake Laboratory reported in Science a high-throughput platform for engineering fast-acting covalent protein...

Tiger BioSciences announced the launch of carePAC™, a line of pre-configured wound care convenience kits designed to simplify dressing changes and improve access to essential wound care supplies for...

Thermo Fisher Scientific the world leader in serving science, announced a next-generation, integrated cell line development platform that enables biologics developers to accelerate time to clinic...

Orca Bio, a late-stage biotechnology company committed to transforming the lives of patients through high-precision cell therapy, announced that the U.S. Food and Drug Administration (FDA) has...

CellCentric, a clinical-stage biotechnology company developing inobrodib as a first-in-a-class, oral p300/CBP inhibitor for the treatment of multiple myeloma, announced the initiation of DOMMINO-1, a...

ProductLife Group (PLG), a global provider of consulting and outsourcing services for the life sciences industry, has appointed Dr. James Burt as Chief Executive...

Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today announced its expansion into France, Europe’s second largest...

Oryon Cell Therapies a clinical-stage biotechnology company focused on developing autologous neuron replacement medicines for Parkinson's disease and other neurodegenerative disorders, announced it has...